| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |